Tirzepatide has rapidly become one of the most studied peptides in incretin biology research. As a dual GLP-1/GIP receptor agonist, it represents a structurally and mechanistically distinct class of research compound. Its 39-amino acid sequence, lipidated with a C20 fatty diacid moiety for albumin binding and extended half-life, makes it a uniquely complex molecule to synthesize and characterize.
Access verified quality documentation and research-grade peptides.
View Certificates of Analysis Explore Research-Grade PeptidesDisclaimer: All compounds referenced in this article are intended for laboratory research use only. They are not approved for human or veterinary use by the FDA or any regulatory agency.